(Q33312689)

English

Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Xing Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Bo Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Xiao-shi Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Zhi-ming Li

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Zhong-zhen Guan

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Wen-qi Jiang

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

29 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

235

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Mass spectrometry: uncovering the cancer proteome for diagnostics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Overexpression of alpha-defensin is associated with bladder cancer invasiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Prognostic biomarkers in diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Biomarker discovery for ovarian cancer using SELDI-TOF-MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Molecular pathogenesis of diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Diagnostic potential of serum proteomic patterns in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

A data review and re-assessment of ovarian cancer serum proteomic profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Serum proteomic patterns for detection of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

New approaches to proteomic analysis of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242801

21 June 2018

Altered cognitive function in men treated for prostate cancer with leutinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-235

21 January 2018

Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-235

21 January 2018

Protein profiling in urine for the diagnosis of bladder cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-235

21 January 2018

International prognostic index-based outcomes for diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-235

21 January 2018

Re: Serum proteomic patterns for detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-235

21 January 2018

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-235

21 January 2018

Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-235

21 January 2018

Serum proteomic patterns for detection of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18163913

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-7-235

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33312689&oldid=2195231403"